Technological innovations and combination of external devices with pumps, government initiatives, improving healthcare infrastructure, and the large patient base and Rise in chronic diseases in geriatric population are key factors contributing to high CAGR during the forecast period.
According to the current analysis of Reports and Data, the global Intrathecal Infusion Pumps market was valued at USD 238.2 million in 2018 and is expected to reach USD 368.4 million by the year 2026, at a CAGR of 5.6 %. Intrathecal Infusion Pumps are intrathecal drug delivery systems which provide anesthesia and analgesia. ITDD systems consists of a catheter attached to a pump, and the pump is an external device or an implanted system that involves therapy and drug diagnosis.
Intrathecal Infusion Pumps market is driven by the rising prevalence of sclerosis, movement disorders, infusion and brain injuries, and cerebral palsy. Increase in geriatric population and long-term therapy comprising infusion pump devices and brain injuries is likely to boosts the industrial growth during the forecast period. A rise in chronic diseases in geriatric population and development of medical device and equipment is likely to contribute to market growth during the forecast period. Technological innovations and combination of external devices with pumps that enable low medication dosages accelerates the market growth for the forecast period. Favorable government initiatives, improving healthcare infrastructure, and the large patient base, is projected to support the infusion pump industrial growth in developing regions such as India and China. In November 2014, Tricumed Medizintechnik GmbH launched the implantable, programmable infusion pump for baclofen therapy. Some of the side effects, such as a fluid leak, severe skin reactions, and headache, are expected to hamper market growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2191
The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.
Key companies operating in the market and profiled in the report include:
DePuy Synthes, FlowonixMedical, Inc., Medtronic Plc, Tricumed Medizintechnik GmbH, and Teleflex, Inc.
Order this report @ https://www.reportsanddata.com/report-pricing/2191
The Intrathecal Infusion Pumps market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.
Segments Covered in the report
Applications (Revenue, USD Million; 2016–2026)
- Spasticity Management
- Pain Management
- Non-Malignant Pain
- Malignant Pain
End-Use (Revenue, USD Million; 2016–2026)
- Hospital
- Clinic
- ASCs
- Long term care centers
- Others
Key Regions Analyzed in the Report include:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/infusion-pumps-market
Furthermore, it consists information about individual segment of the Intrathecal Infusion Pumps market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.
Further key findings from the report suggest
- Intrathecal baclofen (ITB) pump implantation can be used to control dystonia and severe pain associated with complex regional pain syndrome (CRPS). CRPS is associated with dysregulation of the central nervous system (CNS), peripheral nervous system, and autonomic nervous system. The pathophysiology and best course of treatment for CRPS are undetermined, and treatment is evolving. Intrathecal baclofen (ITB) pumps have been used to ameliorate global pain in patients with CRPS and dystonia based on the anti-nociceptive effects of ITB.
- Medtronic plc and Samsung Electronics Co., Ltd. declared their collaborative agreement to develop health solutions in the area of neuromodulation.
- The pain management category led the application segment of this industry with the largest revenue share at over 69.4%, due to to the increasing preference for long-term relief alternatives and the high prescription prices associated with conventional opioid drugs used in pain management.
- Spasticity management is growing at the fastest CAGR at over 3.8% throughout the forecast period. The reason for this is rising government initiatives and recommendations, such as by the British Pain Society to promote effective drug delivery in the treatment of spasticity in adults.
- An intrathecal pump can be used to deliver different medications into the intrathecal sac around the infusion cord. Most commonly, the medication is either an opioid for pain, or baclofen for spasticity due to infusion cord injury. The use of intrathecal pumps allow medication to be given in smaller doses because it does not have to be absorbed through the intestines, like a drug taken orally, and then pass through the liver before circulating to the target area.
- The High R&D intensity aimed at developing technologically advanced products is expected to propel the industry growth in the North America region, with the largest revenue share of 54.4%.
- Around 80% of the patient base with cerebral palsy (CP) most often suffers from CP-related spasticity to a certain degree. The statistics above exhibit the clinical urgency to treat spasticity, thus impelling the industry demand during the forecast period.
- Low patient compliance, the high long-term associated costs, and the rising cases of relapse associated with conventional medication methods used in the treatment of spasticity and chronic pain are expected to present the intrathecal Infusion Pumps market with high growth potential.
- Maintenance of the pump is fairly routine. The pump is refilled every 1 to 3 months by inserting a needle through the skin and through a diaphragm on the surface of the pump. Several medications can be administered this way, and even combinations of drugs might be used. Because the whole system is under the skin, the risk of infection is minimized and the patient can be fully mobile and active.
- The non-malignant pain category dominated the overall pain management segment due largely to it being the major burden globally.
- Hospitals end-use segment is dominating the industry with largest share due to the increasing demand of patients for intrathecal Infusion Pumps.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2191
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
Browse More Reports:
Botulinum Toxin Injection Market @ https://www.biospace.com/article/revenue-growth-of-the-global-botulinum-toxin-injection-market-is-significantly-driven-by-improved-access-to-local-service-providers-and-rising-application-in-cosmetic-and-therapeutic-procedures-reports-and-data-/
Galactosidase Market @ https://www.biospace.com/article/galactosidase-industry-analysis-2021-2028-/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
